![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, June 24, 2011 8:56:15 AM
A blog site which promotes the Epione Beverly Hills Cosmetic Surgery Center just posted information about LaViv, which is interesting as it does then list it, as a competitor to Botox.
"Fibrocell Wins FDA Approval for Cell-Based Wrinkle Smoother San Francisco Chronicle The drug will compete with Allergan Inc.'s Botox, a toxic injection that relaxes facial muscles, and wrinkle fillers such as Allergan's Juvederm and Medicis Pharmaceutical Corp.'s Restylane that use animal collagens or chemicals."
----------------------
http://www.kissmybotox.com/botox-news/fibrocell-wins-fda-approval-for-cell-based-wrinkle-smoother-san-francisco-chronicle/
These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM